CSII Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Apr 2023 @ 16:00):

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally...

Stats
Today's Volume	387 776
Average Volume	677 842
Market Cap	843.96M
EPS	$0 ( 2024-02-07 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-20.83
ATR14	$0.103 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-27	Paulsen Erik	Sell	20 627	Restricted Stock Units
2023-04-27	Paulsen Erik	Sell	700	Common Stock
2023-04-27	Points Jeffrey S.	Sell	138 957	Common Stock
2023-04-27	Points Jeffrey S.	Sell	34 051	Common Stock
2023-04-27	Rempe Stephen J.	Sell	75 659	Common Stock

INSIDER POWER
-78.66
Last 100 transactions
Buy: 675 433 \| Sell: 1 911 221

Volume Correlation

Long: 0.24 (neutral)

Short: -0.52 (weak negative)

Signal:(76.086) Neutral

Cardiovascular Systems Correlation

10 Most Positive Correlations
ATCX	0.992
TA	0.978
IIN	0.972
ECHO	0.968
SPRB	0.966
IFRX	0.963
LGMK	0.962
BUR	0.956
EZFL	0.948
SHC	0.947

10 Most Negative Correlations
MDXH	-0.959
TENX	-0.952
SMH	-0.951
BSET	-0.948
SINT	-0.944
ONCT	-0.944
CYXT	-0.944
SIRI	-0.937
VTRU	-0.934
NDRA	-0.934

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cardiovascular Systems Correlation - Currency/Commodity

0.84
( strong )

0.77
( moderate )

-0.75
( moderate negative )

0.80
( strong )

0.30
( neutral )

-0.60
( weak negative )

Cardiovascular Systems Financials

Annual	2022
Revenue:	$236.22M
Gross Profit:	$172.78M (73.14 %)
EPS:	$-0.940

Q2	2023
Revenue:	$61.45M
Gross Profit:	$42.99M (69.96 %)
EPS:	$-0.200

Q1	2023
Revenue:	$59.67M
Gross Profit:	$42.98M (72.02 %)
EPS:	$-0.270

Q4	2022
Revenue:	$62.50M
Gross Profit:	$46.23M (73.97 %)
EPS:	$-0.250

Financial Reports:

No articles found.

Cardiovascular Systems

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.